Crohn's and Colitis Canada
For More Information
For additional information, please visit the Crohn's and Colitis Canada website for
- Program guidelines
- Application forms
- Evaluation criteria
Through the Innovations in IBD (INN) Research Program, Crohn’s and Colitis Canada is committed to funding novel or innovative approaches to IBD research. INN grants support research projects with a defined objective, conducted by an investigator working alone or in collaboration with others. INN grants support research projects directly related to IBD that are aligned with Crohn’s and Colitis Canada’s Promise and strategic directions.
The program is intended to stimulate and support IBD-related research which may not be encompassed within the boundaries of other research funders. This includes pilot projects and high risk but innovative ideas that could potentially contribute significantly to the advancement of finding the cures for Crohn’s disease and ulcerative colitis and/or improving the quality of life of people with these diseases. This competition will fund innovative projects deemed scientifically excellent, will refine hypotheses and/or produce preliminary data that will help seed larger projects, and have the potential to improve diagnosis, therapy, or prevention of IBD.
Applicants submitting an application focused on IBD-associated diseases and conditions must provide a strong rationale for how their project aligns with the Crohn’s and Colitis Canada Promise.
Postdoctoral fellows or investigators who hold an academic appointment at a Canadian University in a Faculty of Medicine, Nursing, Pharmacy, Veterinary Medicine or other Graduate Faculty are eligible to apply to Crohn’s and Colitis Canada as principal investigator for grant support of their research. The research proposed must have a clear connection to Crohn’s and Colitis Canada’s Promise Statement. Principal Investigators must reside in Canada to apply for funding. Co-Principal Investigators based outside of Canada are acceptable.
If an applicant does not hold an academic appointment at the time of submitting an application, a cover letter from the Dean of the Faculty must be uploaded to the application, indicating the planned position and the date it will take effect. Investigators in Faculties other than the health sciences may also apply if the proposed research is deemed relevant to Crohn’s and Colitis Canada’s Promise and strategic directions.
In order to be eligible to receive funding for an INN grant from Crohn’s and Colitis Canada, recipients must be members of the Crohn’s and Colitis Canada IBD Research Institute.
Maximum Project Value
$50,000 per grant
Funding is limited to:
- Pay technician and/or student salaries;
- Purchase materials, supplies, and items of equipment (maximum $5,000 annually);
- Buy and maintain animals, and;
- Support travel costs (maximum $2,500 annually)
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.
If College-level review is required, your College will communicate its earlier internal deadlines.
Applicant to submit a copy of application with signature page (signed by PI and Co-PI) along with complete OR5 form to: email@example.com.
Applicant must complete and submit application via the online application system Proposal Central
See the attached IBD program guidelines for more information.
Information For Co-applicants
If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).
|IBD Application Guidelines||230.96 KB|